The downgrade from Outperform to Market Perform by Barrington Research indicates a less optimistic outlook for the company. The lowered price target from $46 to $45.5 also suggests that the analyst sees less upside potential in the stock, which could negatively impact investor sentiment and put downward pressure on the stock price in the short term.